Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
Volume 22 (2024): Issue 5 (Jul 2024)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
NCCN Guidelines® Insights
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
Oncology Watch
Artificial Intelligence and Oncology
The Last Word
Molecular Tests in Pancreatic Cancer: Critical Role of Molecular Testing, Expanding Access, and Adherence to the NCCN Guidelines for Pancreatic Cancer
NCCN Policy Report
NCCN Policy Summit: Cancer Across Geography
Original Research
Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer
Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population
Cancer Rehabilitation: Impact on Breast Cancer Survivors’ Work Ability and Health-Related Quality of Life
Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials
Changes in New Patient Consultations During the COVID-19 Pandemic at a Canadian Comprehensive Cancer Center
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
Brief Report
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events
Review
Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults
Departments
Highlights of the NCCN Oncology Research Program
NCCN News
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/view/journals/jnccn/22/5/jnccn.22.issue-5.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Search
Issue
Journal
[18.97.9.173]
18.97.9.173
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size